Cargando…
AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling
Heart failure is a progressive, debilitating disease that is characterized by inadequate contractility of the heart. With an aging population, the incidence and economic burden of managing heart failure are anticipated to increase substantially. Drugs for heart failure only slow its progression and...
Autores principales: | Zouein, Fouad A., Booz, George W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732072/ https://www.ncbi.nlm.nih.gov/pubmed/23967378 http://dx.doi.org/10.12703/P5-27 |
Ejemplares similares
-
Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension
por: Altara, Raffaele, et al.
Publicado: (2016) -
Dancing rhinos in stilettos: The amazing saga of the genomic and nongenomic actions of STAT3 in the heart
por: Zouein, Fouad A, et al.
Publicado: (2013) -
Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress
por: Zgheib, Carlos, et al.
Publicado: (2012) -
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
por: Altara, Raffaele, et al.
Publicado: (2016) -
Science unites a troubled world: Lessons from the pandemic
por: Booz, George W., et al.
Publicado: (2021)